This $5.5 Million Exit: Lessons From Wave Life Sciences and a Tough Quarter
A high-stakes exit valued at about $5.5 million and a difficult first quarter have investors re-evaluating risk in bi...
New costs require quick yet thoughtful budget tweaks. This section highlights practical adjustments to preserve balance and grow savings.
27,302 articlesA high-stakes exit valued at about $5.5 million and a difficult first quarter have investors re-evaluating risk in bi...
As chip stocks wobble, there are three AI-focused names that still stand out to me. This guide explains why they matt...
An Ouster director recently disclosed an open-market sale of thousands of shares. This deep dive explains what such m...
A director at Arteris disclosed disposing over 20,000 shares, split between a gift and an open-market sale. Here’s ho...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Nvidia's surge in AI chips is reshaping markets, and some analysts frame it as a $200 billion warning for rivals like...
As AI accelerates, a different kind of winner emerges. This article shows why data-center REITs, not flashy chips, ma...
Investors are weighing AMDs AI bets against its OpenAI ties and the broader AI spending boom. This guide breaks down ...
Oklo stock surged as investors weighed its plans for advanced reactors against the fast-moving AI data-center boom. T...
Pattern PTRN just released its Q1 2026 earnings, revealing growth drivers and fresh guidance. This analysis breaks do...
On Mar. 5, oil surged and AI export worries weighed on tech names, sending the S&P 500, Nasdaq, and Dow lower. This a...
U.S. homeowners hold record equity, but rising borrowing costs and cautious finances are keeping many from drawing on...